Investigating the Effectiveness of Hydrocolloid Dressings Containing Silver in the Treatment of Wounds in the Donor Area of Partial Thickness Skin Seizures

The aim of this study was to determine the effectiveness of hydrocolloid dressings containing silver in the treatment of wounds in the donor area of partial thickness skin seizures.

This randomized clinical trial was conducted on 42 patients who needed partial thickness skin grafts for skin defect reconstruction. After removing the skin graft, the patients were randomly assigned to two groups of hydrocolloid dressing containing silver with Aquacel Ag brand (intervention group) and traditional dressing group (control group). Patients were visited on days 3, 7, 5 and 7, 14 and 21. In each visit, the frequency of dressing change, wound infection, pain during dressing change, the rate and speed of the epithelialization process, and the scar of the wound site were also compared in the two groups at the end of the sixth month. The collected data were analyzed using SPSS version 24 software.

The results showed that there was a statistically significant difference between the average number of times the need for dressing, the degree of epithelialization of the wound, in the two groups of hydrocolloid dressing with silver and traditional dressing (P-value < 0.05); However, there was no statistically significant difference between the mean prevalence of infection, pain during dressing change, vascularity, pigmentation and scar thickness in the two groups of hydrocolloid dressing with silver and traditional dressing (P-value < 0.05).

Overall, the results of this research showed that Aquacel Ag is a safe and effective method for managing the wound in the donor area of partial thickness skin grafts.